Boston Scientific Inc. (BSX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

300 BOSTON SCIENTIFIC WAY MARLBOROUGH, MA 01752-1234

Boston Scientific Inc. develops and markets less-invasive medical devices used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation.

Data as of 2020-08-09
Market Cap55.753 Billion Shares Outstanding1.431 Billion Avg 30-day Volume9.669 Million
P/E Ratio13.8 Dividend Yield EPS2.82
Price/Sales5.489 Price cash flow ratio39.6 Price free cash flow ratio-21.4
Book Value10.92 Price to Tangible Book-33.87 Alpha0.0
Short Interest Ratio1.25 % Short Interest to Float1.0 R-squared0.48555
BETA1.39659 52-week High/Low46.62 / 24.1 Stddev0.08428
View SEC Filings from BSX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 20 14 (0.92%)
13F Filers holding this stock: 759 171 (11.2%)
Aggregate 13F shares on 03/31/2020: 1.256 Billion 556.136 Million
Aggregate 13F shares on 12/31/2019: 1.282 Billion 509.731 Million
Percent change: -2.00% 9.10%
Funds creating new positions: 85 30
Funds Adding to an existing position: 278 68
Funds closing out their position: 130 38
Funds reducing their position: 297 61
Heat Map Ranking for 03/31/2020 213
Heat Map Ranking for 12/31/2019 151
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BSX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BSX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.6 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

1.6 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LENO SAM R

  • Director
44,331 2020-08-10 0

PIERCE DAVID A EVP PRES MEDSURG

  • Officer
7,016 2020-08-03 18

EDDY JODI EUERLE SVP AND CIO

  • Officer
0 2020-08-03 6

MARIO ERNEST

  • Director
10,174 2020-07-31 0

PRANGE KAREN

  • Director
1,935 2020-07-31 0

FLEISHMAN JOEL LAWRENCE

  • Director
14,641 2020-07-30 0

DOCKENDORFF CHARLES J

  • Director
22,323 2020-07-21 1

ZANE ELLEN M

  • Director
6,440 2020-07-21 1

LAVIOLETTE PAUL A

  • Director
0 2020-07-13 0

OLSON SCOTT SVP & PRES, RHYTHM MANAGEMENT

  • Officer
10,578 2020-07-06 1

FITZGERALD JOSEPH MICHAEL EVP & PRES, INTERVEN CARDIO

  • Officer
0 2020-07-01 8

MONSON JONATHAN VP, CORP CONTROLLER AND CAO

  • Officer
34,380 2020-07-01 6

SCANLON MEGHAN SVP,PRES,UROLOGY PELVIC HEALTH

  • Officer
12,269 2020-07-01 6

SPRIGGS OTHA T. III

  • Director
0 2020-06-30 0

CONNORS NELDA J

  • Director
9,831 2020-06-26 1

TOBIN JAMES R

  • Director
4,081 2020-06-24 0

QUINN LUCIA LUCE

  • Director
5,476 2020-06-10 0

BUTCHER ARTHUR C EVP&PRES, ASIA PACIFIC

  • Officer
31,909 2020-06-01 9

CARRUTHERS WENDY

0 2020-05-27 7

LUDWIG EDWARD J

  • Director
22,413 2020-05-14 1

JAMES DONNA

  • Director
0 2020-05-14 1

DEPARLE NANCY ANN

  • Director
18,764 2020-05-14 0

MACMILLAN STEPHEN P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
1,722,442 2020-05-13 1

SUNUNU JOHN E

  • Director
36,155 2020-05-07 2

ROUX DAVID J

  • Director
60,005 2020-05-07 1

FUJIMORI YOSHIAKI

  • Director
0 2020-05-07 1

MAHONEY MICHAEL F

  • Director
21,534 2020-05-05 6

PUCEL KENNETH

  • Director
21,359 2020-03-03 0

BALLINGER KEVIN J. EVP & PRES, INTERVEN CARDIO

  • Officer
80,085 2020-03-03 8

NANAVATY MAULIK SVP & PRES, NEUROMODULATION

  • Officer
259,591 2020-02-28 13

MIRVISS JEFFREY B. SVP&PRES, PERIPH INTERVENT

  • Officer
140,787 2020-02-28 8

BRENNAN DANIEL J. EVP AND CFO

  • Officer
263,243 2020-02-28 8

SORENSON JOHN BRADLEY SVP, MANUF & SUP CHN

  • Officer
45,671 2020-02-28 8

THEPAUT ERIC FRANCIS YVES SVP & PRES, EUR, MID-EAST, AFR

  • Officer
91,796 2020-02-28 8

MACKEY EDWARD F EVP, OPERATIONS

  • Officer
65,709 2020-02-28 6

MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

  • Officer
19,945 2020-02-28 7

KUCHEMAN WILLIAM

  • Director
0 2020-02-26 0

RALLS-MORRISON DESIREE SVP, GC AND CORP SECRETARY

  • Officer
0 2020-02-24 6

WANG XIN WARREN SVP AND PRES, ASIA PACIFIC

  • Officer
78,985 2020-02-15 2

CAPELLO JEFFREY D EVP & CHIEF FINANCIAL OFFICER

  • Officer
3,118 2020-02-12 0

BURNS URSULA M

0 2020-02-05 0

JOHNSON KRISTINA M

  • Director
48,253 2019-12-10 0

BYRNES BRUCE L

  • Director
0 2019-07-25 0

SANDMAN PAUL W

  • Director
0 2019-06-20 0

GILBERT JAMES

  • Director
0 2019-05-01 0

MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

MEREDITH IAN T EVP GLOBAL CHIEF MED OFFICER

  • Officer
6,348 2019-02-28 7

PHALEN MICHAEL P. EVP & PRESIDENT, MEDSURG

  • Officer
133,373 2018-02-28 0

PRATT TIMOTHY A. EVP, GC & CHIEF ADMIN OFFICER

  • Officer
154,681 2017-12-01 0

BOSE SUPRATIM EVP & PRESIDENT, ASIA-PACIFIC

  • Officer
320,301 2017-10-03 0

DAWKINS KEITH D EVP, GLOBAL CHIEF MED. OFF.

  • Officer
68,165 2017-02-28 0

NICHOLAS NJ JR

  • Director
No longer subject to file 2016-05-18 0

FOX MARYE ANNE

  • Director
54,728 2016-05-05 0

NICHOLAS PETER M

  • Director
7,406,541 2016-04-01 0

MCCONNELL WILLIAM F JR

  • Director
0 2015-12-31 0

BURNS BRIAN R EVP, GLOBAL QA/RA

  • Officer
16,235 2015-10-23 0

ABELE JOHN E

  • DIRECTOR EMERITUS
1,344,081 2015-08-20 0

REINHARDT UWE E

  • Director
0 2015-06-25 0

LANCE JEAN FITTERER SVP, ASST GC, BUS & REGIONS

  • Officer
125,690 2015-02-16 0

ONUSCHECK JOHN MICHAEL SVP & PRESIDENT, EUROPE

  • Officer
116,025 2015-01-01 0

BARTLETT KATHARINE T

  • Director
52,464 2013-05-07 0

NEUMANN LAWRENCE R SVP, SPECIAL PROJECTS

  • Officer
77,879 2012-05-10 0

ELLIOTT JOHN RAYMOND

  • Director
0 2012-02-27 0

PEDERSEN JOHN B. PRES, URO & WOMEN'S HEALTH

  • Officer
No longer subject to file 2012-02-16 0

PEPPER JOHN E

  • Director
109,346 2011-12-31 0

MORECI STEPHEN F SVP, GLOBAL SALES OPERATIONS

  • Officer
44,579 2011-07-01 0

GROVES RAY J

  • Director
0 2011-03-31 0

MILANI ANDREW N

  • FORMER SVP, HUMAN RESOURCES
No longer subject to file 2010-12-31 0

COLEN FRED EVP & CHIEF TECHNOLOGY OFFICER

  • Officer
73,404 2010-05-10 0

MCFAUL DAVID W SVP, INTERNATIONAL

  • Officer
No longer subject to file 2010-02-12 0

PAUL DONOVAN SVP, CORPORATE COMMUNICATIONS

  • Officer
No longer subject to file 2010-02-12 0

BAIM DONALD S EVP, CHIEF MED. & SCI. OFFICER

  • Officer
53,788 2009-07-10 0

RUDMAN WARREN B

  • Director
0 2009-05-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

EDDY JODI EUERLE - Officer SVP AND CIO

2020-08-03 A 7,894 a 7,894 0.00 direct

PIERCE DAVID A - Officer EVP PRES MEDSURG

2020-08-03 S 2,385 $38.69 d 7,016 7,016.00 direct yes

EDDY JODI EUERLE - Officer SVP AND CIO

2020-08-03 A 32,930 a 32,930 0.00 direct

PIERCE DAVID A - Officer EVP PRES MEDSURG

2020-07-22 S 2,170 $38.00 d 9,401 9,401.00 direct yes

FITZGERALD JOSEPH MICHAEL - Officer EVP & PRES, INTERVEN CARDIO

2020-07-01 A 116,959 a 116,959 0.00 direct

MONSON JONATHAN - Officer VP, CORP CONTROLLER AND CAO

2020-07-01 F 221 $35.28 d 34,380 34,380.00 direct

SCANLON MEGHAN - Officer SVP,PRES,UROLOGY PELVIC HEALTH

2020-07-01 F 260 $35.28 d 12,269 12,269.00 direct

MONSON JONATHAN - Officer VP, CORP CONTROLLER AND CAO

2020-07-01 M 728 a 34,601 34,380.00 direct

SCANLON MEGHAN - Officer SVP,PRES,UROLOGY PELVIC HEALTH

2020-07-01 M 854 a 12,529 12,269.00 direct

MONSON JONATHAN - Officer VP, CORP CONTROLLER AND CAO

2020-07-01 M 728 d 2,185 34,380.00 direct

SCANLON MEGHAN - Officer SVP,PRES,UROLOGY PELVIC HEALTH

2020-07-01 M 854 d 855 12,269.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments